Microbot Medical (MBOT) Asset Writedowns and Impairment (2014 - 2022)

Microbot Medical (MBOT) posted Asset Writedowns and Impairment of $1000.0 for Q1 2022, down 99.58% on a QoQ basis from $239000.0 in Q4 2015.

Microbot Medical (MBOT) Asset Writedowns and Impairment (2014 - 2022) Analysis & Trends

Microbot Medical's Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at $1000.0 for Q1 2022.

Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $1000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $2.7 million (changed N/A YoY) and the FY2015 annual result came in at $239241.0, changed N/A from the prior year.
Asset Writedowns and Impairment was $1000.0 for Q1 2022 at Microbot Medical, down from $239000.0 in the prior quarter.
Across five years, Asset Writedowns and Impairment topped out at $1000.0 in Q1 2022 and bottomed at $1000.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	124.80 Bn	119.58 Bn	1.96 Bn
2	Becton Dickinson	44.47 Bn	43.65 Bn	2.15 Bn
3	Alcon	33.17 Bn	31.51 Bn	1.53 Bn
4	Medline	32.67 Bn	30.44 Bn	1.84 Bn
5	Resmed	29.06 Bn	27.40 Bn	890.98 Mn
6	West Pharmaceutical Services	23.50 Bn	23.06 Bn	329.20 Mn
7	Solventum	13.91 Bn	13.35 Bn	1.10 Bn
8	Cooper Companies	13.82 Bn	13.68 Bn	735.40 Mn
9	Align Technology	12.13 Bn	11.07 Bn	736.59 Mn
10	Microbot Medical	118.87 Mn	49.83 Mn	2,000.00

Download Data